US Stock Market Movement: SL Science surges on October 15th driven by glioblastoma data and γδT therapy
Bitget异动解读2026/10/15 16:35SL Science October 15 Major Surge Interpretation
Keywords: Glioma data, γδT therapy
1. On September 24, 2026, the company announced preclinical data on γδT cell therapy for glioblastoma: it showed preferential killing of MGMT-positive tumor cells, demonstrated a dose-dependent reduction of tumor cells in U87MG, T98G, and LN229 cell lines, and reduced tumor size and prolonged survival in intracranial models.
2. From September 24 to 26, 2026, the related research was presented as Poster P-2017 at the 85th Annual Meeting of the Japanese Cancer Association; the study was conducted in collaboration with Taipei Medical University, JY BioMed, and HeXun Biosciences, involving the company's γδT cell therapy platform and glioblastoma research direction.
(Disclaimer: This content is summarized from publicly available information by AI technology and is for reference only. It does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
